 effect inhal budesonid spirometr valu revers respons cough threshold smoker chronic obstruct lung diseas corticosteroid respiratori symptom respons allerg patient asthma aim present doubl blind studi effect week treatment inhal budesonid non-allerg smoker chronic obstruct lung diseas subject male studi age year mean pack year smoke mean rang geometr mean histamin concentr fall mg/ml week washout singl blind placebo period patient treatment budesonid microgram/day week addit drug ipratropium twenti patient studi budesonid group placebo group standard deviat differ duplic measur histamin citric acid cough threshold week dose step signific reduct dyspnoea budesonid group chang symptom score use ipratropium bromid week treatment group signific differ spirometr valu peak expiratori flow histamin citric acid cough threshold group differ signific chang trend favour budesonid observ period signific influenc inhal corticosteroid patient chronic obstruct lung diseas